RenovaCare, Inc. (RCAR)

Market Cap	87.00
Revenue (ttm)	n/a
Net Income	-5.74M
EPS	-0.07
Shares Out	87.35M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,335
Open	0.0002
Previous Close	0.0001
Day's Range	0.0001 - 0.0002
52-Week Range	0.000001 - 0.0010
Beta	-92.32
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About RenovaCare

RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System, a treatment methodology for cell isolation for the regeneration of human skin cells; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. RenovaCare, Inc. has a strategic collaboration StemCell Systems GmbH for isolating and spraying self-donated stem cells to regener...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1983
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: RCAR

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 16, 2026

Data Sources Report a data error